shagun arora
@shagunaroramducsf malignant & classic hematology | plasma cell dyscrasias | avid adventurer & clinician educator | indian midwesterner loving california living
Similar User
@bitafakhri
@TomBmt133
@SandyWong02111
@abdulmoiz92
@RahulBanerjeeMD
@s_brond
@KVanLoonMD
@dma966
@HerveyJumper
@ANCO_News
@AnnaSchuh3
@MazieTsangMD
@AjaiChari
@MarkYarchoan
@annap_MD
Thank you @drkomanduri and @UCSFHospitals for the invitation to talk about the work my team is doing, and for your partnership on the MEASURE clinical protocol to prospectively validate Measurable Residual Disease (MRD) testing for patients with AML. Also managed to slide in the…
At @UCSFCancer Hem/Onc Grand Rounds this morning, @DrChrisHourigan of @virginia_tech describing the important MEASURE study, which I'm proud to say includes participation both from @UCSFHospitals and my prior center @SylvesterCancer Important @nmdp_org @USNavyResearch study.
🧵 I would add that in addition to questionable (IMHO little to no) benefit the costs of MOC end up in the health care system. That money comes from somewhere, whether it is the pockets of physicians, patients or both. #EndMOC
US physicians almost unanimously oppose ABIM MOC. #MedTwitter We have raised our voice in despair. What can we do to make change happen? 1) Urge our professional organizations to support us. More than words, we would like action.
Register now: "Institutional Perspectives in Cancer: Multiple Myeloma" January 26, 2023 @OncLive WEBINAR with Tom Martin @TomBmt133 @UCSFHospitals ow.ly/Vern50LHw8x
The most important trial at #ASH22: NEUTRODIET, a randomized multicenter trial of 'neutropenic diet' vs normal diet after auto/alloSCT. No differences in infections, aGHVD or hospital days between arms. Less weight loss & better patient satisfaction in normal diet arm! #tcellrx
This is disappointing. The NEJM 2022;387:468-470 article showed that of the FDA approved drugs, only bebtelovimab effectively neutralized the recent COVID strains. Now what? We need to return to the basics. Masking, hand washing, protecting our vulnerable. #CovidIsntOver
Today, FDA is announcing that bebtelovimab is not currently authorized for emergency use in any U.S. region because it is not expected to neutralize Omicron subvariants BQ.1 and BQ.1.1: fda.gov/drugs/drug-saf…
Incredibly important (and devastating) work by @UCSF third-year fellow @meera_ragavan and mentors on the impact of #cancer on financial security. @UCSFCancer @familyreach
Today, FDA is announcing that bebtelovimab is not currently authorized for emergency use in any U.S. region because it is not expected to neutralize Omicron subvariants BQ.1 and BQ.1.1: fda.gov/drugs/drug-saf…
A student interested in #oncology asked me: How to balance the excitement over oncologic diagnosis and treatment with the fact that cancer is devastating for people? A key question. Totally ok to nerd out (I do a lot), but don’t let intellectual enthusiasm overshadow compassion.
Sarina Esmailzadeh, 16, beaten to death by Iranian security forces for protesting for women’s rights in Iran. Nika Shakarami, 16, killed after burning her headscarf in protest. Hadis Najafi, 23, shot multiple times during demonstrations sparked by the death of Mahsa Amini, 22,
Great @UCSF Medicine Grand Rounds on #LongCovid, w/ @LekshmiMD, @MichaelPelusoMD, @zalali I think folks are now recognizing risk of prolonged sxs, but haven't wrapped their heads around long-term risk of non-communicable diseases. It's real, & concerning. youtube.com/watch?v=YGAfCW…
They finished 4-years of undergrad, 4-years of medical school, endured 3-7 years of residency (some going on to get other degrees!), work 50-90 hrs a week... and you still can't call female physicians "Doctor" when you email or send them a message? jamanetwork.com/journals/jaman…
Finished an advance copy of @DrSidMukherjee new book “The Song of the Cell” out 10/25. It’s another masterful work by this author; a sweeping treatise on the discovery of cell functions, how they sometimes go awry in disease, and can be manipulated to create new therapies
Teclistamab BCMA-CD3 targeted bispecific monoclonal antibody was just approved in Europe for the treatment of multiple myeloma. A huge step forward for individual patients and for the field overall! #mmsm @IMFmyeloma @theMMRF @healthtreeforMM @SylvesterCancer
We're pleased to announce the European Commission granted a Conditional Marketing Authorization for our latest #multiplemyeloma treatment. #MMSM
FDA Grants Breakthrough Therapy Designation to Talquetamab for Relapsed/Refractory Myeloma onclive.com/view/fda-grant…
Great BA.5 primer by @EricTopol Key points: 1) Will be dominant variant soon 2) ⬆infectious & ⬆immune evasive vs prior variants 3) Severity unclear, but some ⬆hospitalizations 4) Adds to case for 2nd boost & masking 5) New bivalent vax may not add much erictopol.substack.com/p/the-ba5-story
Come check out some #MedEd projects at the @ASCO poster session! Fun doing these projects with fellow ESP alum @tpjmd @Stanford, #workspouse @shagunaroramd, and other amazing @UCSF @UCSFMedicine @UCSFNeuro @UCSFCancer colleagues! #OncMedEdCoP
Studies suggest that while people are most likely to test positive on antigen tests during the first week of illness, a notable subset of people continue to test positive for 10 days or longer. nyti.ms/3M13BsA
Stem cell in Spanish is "célula madre" which I find very perfect! Happy Mother's day!
Check out this super cool undertaking by @UCSF @UCSFIMChiefs Dr. @JordynSilvs (future oncologist extraordinaire), a podcast to explain #cancer to the public. @ASCO @HemOncFellows @OsherMiniMed
Launched my first episode of my Let's Talk Cancer Podcast with the incredible Dr. Brondfield on "What is Cancer?" A patient facing podcast that allows easy access to information about cancer. @s_brond open.spotify.com/episode/52nZWp…
Epic
Today marks 100.00 months that I’ve been in remission on sirolimus—the drug I identified as promising & tested on myself! If you’ve read #ChasingMyCure or asked me how long I’ve been in remission, you’ll know I always share the length of my remission in fractions of months…
United States Trends
- 1. Cowboys 65,6 B posts
- 2. Texans 55,3 B posts
- 3. Cooper Rush 11,5 B posts
- 4. Jerry 41,6 B posts
- 5. Mike McCarthy 2.967 posts
- 6. Mixon 16,7 B posts
- 7. Trey Lance 3.006 posts
- 8. #WWERaw 60 B posts
- 9. Dyson Daniels 1.984 posts
- 10. Keon Ellis 1.406 posts
- 11. #HOUvsDAL 9.166 posts
- 12. Sixers 10,6 B posts
- 13. Pulisic 22,4 B posts
- 14. Aubrey 15,5 B posts
- 15. The Herta 16,2 B posts
- 16. Derek Barnett 1.763 posts
- 17. #HTownMade 3.616 posts
- 18. Zack Martin N/A
- 19. Pitre 1.522 posts
- 20. Guyton 1.405 posts
Who to follow
-
Bita Fakhri
@bitafakhri -
Tom Martin
@TomBmt133 -
Sandy Wong
@SandyWong02111 -
Abdul Moiz Khan
@abdulmoiz92 -
Rahul Banerjee, MD, FACP
@RahulBanerjeeMD -
Sam Brondfield, MD, MAEd
@s_brond -
Katherine Van Loon, MD, MPH
@KVanLoonMD -
Dina Alali 🇰🇼
@dma966 -
Shawn Hervey-Jumper
@HerveyJumper -
ANCO
@ANCO_News -
Anna Schuh
@AnnaSchuh3 -
Mazie Tsang, MD, MAS, MS
@MazieTsangMD -
Ajai Chari
@AjaiChari -
Mark Yarchoan
@MarkYarchoan -
Anna Parks
@annap_MD
Something went wrong.
Something went wrong.